Home » Clinical Trials » Leukemia » NCT06730256
NCT06730256

A Clinical Study to Explore the Safety, Efficacy, and Pharmacokinetics of CT0596 CAR-T Cell Injection in Patients With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia

Study Summary

A Clinical Study to Explore the Safety, Efficacy, and Cellular Metabolic Dynamics of CT0596 CAR-T Cell Injection in Patients With Relapsed/Refractory Multiple Myeloma and Plasma Cell Leukemia.

Want to learn more about this trial?

Request More Info

Interventions

CAR-T cells Infusion chimeric antigen receptor T cellsDRUG
CAR-T cells Infusion chimeric antigen receptor T cells

Study Locations

FacilityCityStateCountry
The First Affiliated Hospital of Soochow UniversitySuzhouJiangsuChina

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026